MODERN RHEUMATOLOGY CASE REPORTS
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Journal Specifications
Indexed in the following public directories
Web of Science
- PublisherOXFORD UNIV PRESS
- FrequencySemi-annual
- FrequencySemi-annual
- Publisher URL
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
How frequently is the MODERN RHEUMATOLOGY CASE REPORTS published? 
MODERN RHEUMATOLOGY CASE REPORTS is published Semi-annual.
Who is the publisher of MODERN RHEUMATOLOGY CASE REPORTS?
The publisher of MODERN RHEUMATOLOGY CASE REPORTS is OXFORD UNIV PRESS.
How can I view the journal metrics of MODERN RHEUMATOLOGY CASE REPORTS on editage?
For the MODERN RHEUMATOLOGY CASE REPORTS metrics, please refer to the section above on the page.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Rheumatoid arthritis, Amyloidosis, Giant cell, Methotrexate, Tocilizumab, Rituximab, Septic arthritis, Vasculitis, Magnetic resonance imaging, Anasarca, Intestinal ulcers, Cerebrospinal fluid, Dermatomyositis, Lung, Limbic encephalitis, Etanercept, Antiphospholipid syndrome, Denosumab, Ganglion cyst, Acne.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.